Aminex Therapeutics aminextx.com


Public list: Pharma Startups (4729) Cancer Therapeutics (1132)

Aminex Therapeutics is a drug development company focused on discovery, development, and commercialization of a new subclass of cancer immunotherapies known as suppressor cell modulators (SCMs). Aminex's novel cancer immunotherapy drug, AMX-513, enables the body's immune system to attack cancer and its ability to spread by modulating myeloid-derived suppressor cells (MDSCs).

Aminex Therapeutics is a drug development company focused on discovery, development, and commercialization of a new subclass of cancer immunotherapies known as suppressor cell modulators (SCMs). Aminex's novel cancer immunotherapy drug, AMX-513, en...Show all

Company (Alive / Active)

Phone: 425-286-4222

Fax:

11335 NE 122nd
Suite 105
Kirkland, 98034
Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aminex Therapeutics $6M Nov 10, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aminex Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Hydrophobic polyamine analogs and methods for their use Jan 08, 2002 Apr 24, 2012 Patent
Surgical device with integrated visualization and cauterization Dec 02, 2015 Application
Methods for enhancing immune response Nov 03, 2014 Application